Editor-in-Chief
- Clive Grattan, Norfolk and Norwich University Hospital
Society Affiliations
Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology.
Articles
-
Review
Clinical and Translational Allergy 2012, 2:8 (13 April 2012)Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy
-
Research
Clinical and Translational Allergy 2012, 2:7 (22 March 2012)Repeated allergen exposure reduce early phase airway response and leukotriene release despite upregulation of 5-lipoxygenase pathways
-
Retraction
Clinical and Translational Allergy 2012, 2:6 (16 March 2012)Retraction: Vitamin C and asthma in children: modification of the effect by age, exposure to dampness and the severity of asthma
-
Review
Clinical and Translational Allergy 2012, 2:5 (9 March 2012)FAST: Towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies
-
Research
Clinical and Translational Allergy 2012, 2:4 (5 March 2012)Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions
-
Research
Clinical and Translational Allergy 2012, 2:3 (2 February 2012)What factors affect the carriage of epinephrine auto-injectors by teenagers?
-
Review
Clinical and Translational Allergy 2012, 2:2 (5 January 2012)Mechanisms of allergen-specific immunotherapy
- View more articles
Editor's profile
Clive Grattan
Clive Grattan, MA, MD, FRCP, is currently Consultant Dermatologist at the Norfolk and Norwich University Hospital and St John's Institute of Dermatology, London, UK. Since 2011 he is also Chair of the Dermatology Section of the Academy of Allergy and Clinical Immunology (EAACI), the academic association behind this journal.
"Clinical and Translational Allergy is a pioneering initiative to make high quality peer-reviewed research and reviews in Allergy and related subjects available to clinicians, scientists and the public in an open-access format. Authors retain copyright of their material. The journal is now indexed in PubMed Central and new publications will therefore have wide exposure. Advances in allergy and immunology are being made in the clinic and in the laboratory at a rapid rate. CTA provides the platform for rapid dissemination of these findings to a wide audience to provide greatest impact and benefit to society. The challenge of launching a new journal is already past and now is the time to project CTA into the future as the premier online resource for allergy research."
Aims & scope
Clinical and Translational Allergy is a peer reviewed open access journal aiming to provide a platform to publish original research and reviews in the field of allergy. Such articles can be based on clinical, translational or basic research.
Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, and is one of the first open access journals in this field. Open access publishing enables free access to all contents ensuring a wide dissemination of articles; the electronic format and the optimised manuscript handling process allows very rapid publication of papers.
Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute. Clinical and Translational Allergy publishes original research articles and reviews, as well as EAACI position articles, EAACI Task Force Reports and EAACI guidelines.
Call for papers
Advances in food allergy 2012
Clinical & Translational Allergy is currently inviting submissions on food allergy for a 2012 cross-journal collection.
Clinical & Translational Allergy is working with Allergy, Asthma & Clinical Immunology and Clinical and Molecular Allergy to promote the advancement in knowledge on food allergy.
We are looking for original research and reviews on all aspects of food allergy, including diagnosis - from molecular to clinical, and the mechanisms involved in sensitisation, allergy manifestations and tolerance. All manuscripts will undergo full peer-review in line with the journal's standard policy. Please see our instructions for authors for further details. We would like to invite you to submit your manuscript. When doing so, please indicate that you would like your manuscript to be considered for the special collection.
The closing date for submissions is 30th September 2012.
View articles already published in the series here.
Society information
The European Academy of Allergy and Immunology (EAACI) is an association of clinicians, researchers and allied health professionals, dedicated to improving the health of people affected by allergic diseases. With over 6,100 individual members and 41 European National Societies, EAACI is the primary source of expertise in Europe for all aspects of allergy.
EAACI was established in 1956 and has held over 50 European congresses and annual meetings in various European cities, providing opportunities for sharing ideas, knowledge and best clinical practice, creating clinical and scientific networks, and building links between all those interested in the study and treatment of allergic disorders.
For more information please visit www.eaaci.net.
Email updates
Receive periodic news and updates relating to this journal.